Pieter Stokkers

Author PubWeight™ 13.70^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.	Gastroenterology	2009	2.26
2	Genome-wide association analysis in primary sclerosing cholangitis.	Gastroenterology	2009	1.69
3	Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.	J Mol Med (Berl)	2005	1.54
4	Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.	Gut	2010	1.53
5	Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.	Nat Genet	2010	1.43
6	Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p.	Proc Natl Acad Sci U S A	2001	1.17
7	Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.	Gut	2013	1.02
8	A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis.	J Clin Gastroenterol	2008	0.91
9	Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis.	Hum Immunol	2011	0.79
10	Genomics and proteomics: implications for inflammatory bowel diseases.	Inflamm Bowel Dis	2004	0.79
11	Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.	Inflamm Bowel Dis	2010	0.78